首页> 外国专利> Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes

Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes

机译:病毒唑在活化的T淋巴细胞中对Th1 / Th2细胞因子表达的特异性调节

摘要

Ribavirin is employed in a manner which is effective to modulate lymphokine expression in activated T cells. In particular, Ribavirin is used to suppress Type 2-mediated T cell responses and promote Type 1-mediated T cell response. Thus, instead of administering Ribavirin in its well-recognized role as an anti-viral agent, Ribavirin is herein used in the treatment of imbalances in lymphokine expression. Such imbalances may be found to be concomitants of allergic atopic disorders such as allergic asthma and atopic dermatitis, helminth infection and leishmaniasis, and various primary and secondary immunodeficiencies, which may or may not also be associated with viral infection.
机译:利巴韦林以有效调节活化的T细胞中淋巴因子表达的方式使用。特别地,利巴韦林用于抑制2型介导的T细胞应答并促进1型介导的T细胞应答。因此,代替以其公认的抗病毒剂作用给予利巴韦林,本文将利巴韦林用于治疗淋巴因子表达的失衡。可以发现这种失衡是伴随过敏性特应性疾病,例如过敏性哮喘和特应性皮炎,蠕虫感染和利什曼病,以及各种原发性和继发性免疫缺陷,可能与病毒感染有关也可能与病毒感染无关。

著录项

  • 公开/公告号US2003212015A1

    专利类型

  • 公开/公告日2003-11-13

    原文格式PDF

  • 申请/专利权人 TAM ROBERT;

    申请/专利号US20030460897

  • 发明设计人 ROBERT TAM;

    申请日2003-06-12

  • 分类号A61K31/7056;

  • 国家 US

  • 入库时间 2022-08-21 23:16:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号